Aspirin controls two key processes to kill bowel cancer cells Aspirin kills malignancy cells by controlling two essential processes that influence energy make use of in cells and may explain how aspirin can prevent bowel cancer. The research is released in this month’s Gastroenterology. Cancer Study UK-funded scientists have found that aspirin switches off mTOR, a protein that’s overactive in bowel tumor cells www.malegra-plus.com/malegra-fxt-and-malegra-fxt-plus-directions-for-use.htm . MTOR has a component in allowing malignancy cells to produce excessive proteins causing them to grow faster than they should. Simultaneously, aspirin activates another protein, AMPK, which switches on pathways that generate energy but halts other procedures in the cell that require energy, including mTOR.